Cardiovascular and Neuromuscular Effects of Org NC 45, Pancuronium, Metocurine, and d‐Tubocurarine in Dogs

We compared the cardiovascular and neuromuscular effects of Org NC 45 with those of pancuronium, metocurine, and d-tubocurarine in six dogs anesthetized with halothane. The ED90 (dose of drug which produced a 90% depression of twitch tension) of Org NC 45, pancuronium, metocurine, and d-tubocurarine was 14 ± 3, 22 ± 3, 63 ± 19, and 130 ± 19 μg/kg, respectively. All subsequent neuromuscular and cardiovascular effects were determined from a dose equal to 3 times the ED90 of muscle relaxant. Org NC 45, pancuronium, metocurine, and d-tubocurarine produced a neuromuscular blockade with a duration (time from relaxant administration until recovery of 50% of the original twitch tension) of 42 ± 2, 108 ± 10, 109 ± 21, and 100 ± 19 minutes, respectively. Org NC 45 caused no significant cardiovascular changes. Pancuronium increased heart rate, mean arterial blood pressure, cardiac output, and pulmonary wedge pressure, and it decreased systemic vascular resistance (p < 0.05). Although metocurine also increased heart rate and cardiac output (p < 0.05), mean arterial blood pressure and pulmonary wedge pressure did not change. d-Tubocurarine decreased all cardiovascular parameters except heart rate which increased significantly (p < 0.05). We conclude that Org NC 45 produces a neuromuscular blockade of shorter duration with fewer cardiovascular changes than that of pancuronium, metocurine, or d-tubocurarine.

[1]  I. G. Marshall,et al.  The neuromuscular and autonomic blocking activities of pancuronium, Org NC 45, and other pancuronium analogues, in the cat , 1979, The Journal of pharmacy and pharmacology.

[2]  R. Gardier,et al.  The effect of pancuronium and gallamine on muscarinic transmission in the superior cervical ganglion. , 1978, The Journal of pharmacology and experimental therapeutics.

[3]  J. Chamberlain,et al.  Myocardial stimulation by pancuronium bromide. , 1978, British journal of anaesthesia.

[4]  T. Stanley,et al.  Cardiovascular Effects of Meperidine‐N2O Anesthesia Before and After Pancuronium , 1977, Anesthesia and analgesia.

[5]  H. H. Ali,et al.  The Clinical Pharmacology of Metocurine: Dimethyltubocurarine Revisited , 1977, Anesthesiology.

[6]  J. Zaidan,et al.  Hemodynamic Effects of Metocurine in Patients with Coronary Artery Disease Receiving Propranolol , 1977, Anesthesia and analgesia.

[7]  J. Oroz,et al.  Pancuronium bromide: an indirect sympathomimetic agent. , 1976, British journal of anaesthesia.

[8]  R. Albrecht,et al.  The effect of pancuronium on myocardial contraction and catecholamine metabolism. , 1976, The Journal of pharmacy and pharmacology.

[9]  E. Eger,et al.  Pancuronium-induced tachycardia in relation to alveolar halothane, dose of pancuronium, and prior atropine. , 1975, Anesthesiology.

[10]  V. Barnett,et al.  Applied Linear Statistical Models , 1975 .

[11]  H. H. Ali,et al.  A New Approach to the Study of Four Nondepolarizing Relaxants in Man , 1974, Anesthesia and analgesia.

[12]  R. Stoelting The hemodynamic effects of pancuronium and d-tubocurarine in anesthetized patients. , 1972, Anesthesiology.

[13]  R. Hughes Haemodynamic effects of tubocurarine, gallamine and suxamethonium in dogs. , 1970, British journal of anaesthesia.

[14]  I. Bonta,et al.  Mechanism of selective cardiac vagolytic action of pancuronium bromide. Specific blockade of cardiac muscarinic receptors. , 1970, European journal of pharmacology.